ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2016

Long-term administration of the mitochondria-targeted antioxidant mitoquinone mesylate fails to attenuate age-related oxidative damage or rescue the loss of muscle mass and function associated with aging of skeletal muscle.

Giorgos K Sakellariou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.